Sector: In Vitro & In Vivo Diagnostic SubstancesIndustry: BiotechnologyCountry: GBExchange: Nasdaq
DilutionScan read 32 of Virax Biolabs Group Ltd's SEC filings and found 10 warrant series, 1 ATM program, 3 shelf registrations and 4 completed offerings on file for VRAX. The latest dilution event on file is ATM sales on Sep 4, 2026. Analysis updated Sep 16, 2026.
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z
SPRCSciSparc Ltd. Ordinary Shares
BBLGBone Biologics Corporation
ARTLArtelo Biosciences, Inc.
GOVXGeoVax Labs, Inc.
OGENOragenics, Inc.
SCNIScinai Immunotherapeutics Ltd. American Depositary Shares
KAPAKairos Pharma, Ltd.
VBIOValion Bio, Inc.
MTNBMatinas BioPharma Holdings, Inc.
MLECMoolec Science SA Ordinary Shares
ELABPMGC Holdings Inc.
PPCBPropanc Biopharma, Inc. Common Stock
XRTXXORTX Therapeutics Inc.
JAGXJaguar Health, Inc.
GNPXGenprex, Inc.